mRNA Cancer Vaccines and Therapeutics Market Report

Global and China mRNA Cancer Vaccines and Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 01, 2022
  • PAGES：181
  • REPORT CODE：GMM1333834
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the mRNA Cancer Vaccines and Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • In-Cell-Art

    • Sangamo Therapeutics

    • Translate Bio

    • Argos Therapeutics

    • Ethris

    • CureVac

    • Tiba Biotechnology

    • BioNTech

    • eTheRNA

    • Moderna Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Adeno Carcinomas

    • Mucinous Carcinomas

    • Adenosquamous Carcinomas

    Application:

    • Infectious Disease

    • Cancer

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 mRNA Cancer Vaccines and Therapeutics Industry Overview

      • 1.1.1 mRNA Cancer Vaccines and Therapeutics Market Scope and Market Segments

      • 1.1.2 mRNA Cancer Vaccines and Therapeutics Industry Characteristics

      • 1.1.3 Global and China mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China mRNA Cancer Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Adeno Carcinomas

      • 1.2.2 Mucinous Carcinomas

      • 1.2.3 Adenosquamous Carcinomas

    • 1.3 Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Infectious Disease

      • 1.3.2 Cancer

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global mRNA Cancer Vaccines and Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 mRNA Cancer Vaccines and Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 mRNA Cancer Vaccines and Therapeutics Industry PEST Analysis

    • 2.3 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 mRNA Cancer Vaccines and Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on mRNA Cancer Vaccines and Therapeutics Industry

    Chapter 3 Global and China mRNA Cancer Vaccines and Therapeutics Market, by Manufacturer

    • 3.1 Global and China mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China mRNA Cancer Vaccines and Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China mRNA Cancer Vaccines and Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China mRNA Cancer Vaccines and Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China mRNA Cancer Vaccines and Therapeutics Market Top 3 Players

    Chapter 4 Global and China mRNA Cancer Vaccines and Therapeutics Market, by Type (2017-2028)

    • 4.1 mRNA Cancer Vaccines and Therapeutics Market Trend, by Type

    • 4.2 Global mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global mRNA Cancer Vaccines and Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global mRNA Cancer Vaccines and Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global mRNA Cancer Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China mRNA Cancer Vaccines and Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China mRNA Cancer Vaccines and Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China mRNA Cancer Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China mRNA Cancer Vaccines and Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global mRNA Cancer Vaccines and Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global mRNA Cancer Vaccines and Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China mRNA Cancer Vaccines and Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China mRNA Cancer Vaccines and Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America mRNA Cancer Vaccines and Therapeutics Market Analysis

    • 7.1 North America mRNA Cancer Vaccines and Therapeutics Market, by Type

    • 7.2 North America mRNA Cancer Vaccines and Therapeutics Market, by Application

    • 7.3 North America mRNA Cancer Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe mRNA Cancer Vaccines and Therapeutics Market Analysis

    • 8.1 Europe mRNA Cancer Vaccines and Therapeutics Market, by Type

    • 8.2 Europe mRNA Cancer Vaccines and Therapeutics Market, by Application

    • 8.3 Europe mRNA Cancer Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC mRNA Cancer Vaccines and Therapeutics Market Analysis

    • 9.1 APAC mRNA Cancer Vaccines and Therapeutics Market, by Type

    • 9.2 APAC mRNA Cancer Vaccines and Therapeutics Market, by Application

    • 9.3 APAC mRNA Cancer Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina mRNA Cancer Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China mRNA Cancer Vaccines and Therapeutics Company Profiles

      • 11.1 In-Cell-Art

        • 11.1.1 In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.1.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sangamo Therapeutics

        • 11.2.1 Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Translate Bio

        • 11.3.1 Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Argos Therapeutics

        • 11.4.1 Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Ethris

        • 11.5.1 Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Ethris mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 CureVac

        • 11.6.1 CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.6.3 CureVac mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Tiba Biotechnology

        • 11.7.1 Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 BioNTech

        • 11.8.1 BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.8.3 BioNTech mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 eTheRNA

        • 11.9.1 eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.9.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Moderna Therapeutics

        • 11.10.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Profiles, Application and Specification

        • 11.10.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 mRNA Cancer Vaccines and Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 mRNA Cancer Vaccines and Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 mRNA Cancer Vaccines and Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Adeno Carcinomas (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Mucinous Carcinomas (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Adenosquamous Carcinomas (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate of Other (2017-2028)

    • Figure North America mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China mRNA Cancer Vaccines and Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China mRNA Cancer Vaccines and Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China mRNA Cancer Vaccines and Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China mRNA Cancer Vaccines and Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China mRNA Cancer Vaccines and Therapeutics Market Share, by Manufacturer in 2022

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Value, by Type (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Value, by Type (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Price Trend, by Type (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Value, by Application (2017-2028)

    • Table Global mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Value, by Application (2017-2028)

    • Table China mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina mRNA Cancer Vaccines and Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina mRNA Cancer Vaccines and Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table In-Cell-Art Product Profiles, Application and Specification

    • Table In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sangamo Therapeutics Product Profiles, Application and Specification

    • Table Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Translate Bio Product Profiles, Application and Specification

    • Table Translate Bio mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Argos Therapeutics Product Profiles, Application and Specification

    • Table Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ethris Product Profiles, Application and Specification

    • Table Ethris mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CureVac Product Profiles, Application and Specification

    • Table CureVac mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tiba Biotechnology Product Profiles, Application and Specification

    • Table Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioNTech Product Profiles, Application and Specification

    • Table BioNTech mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table eTheRNA Product Profiles, Application and Specification

    • Table eTheRNA mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Moderna Therapeutics Product Profiles, Application and Specification

    • Table Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US